About MAOLAC
MAOLAC is a company based in Jerusalem (Israel) founded in 2020 by Eli Lerner, Maya Ashkenazi, and Ariel Orbach. MAOLAC has raised $3.2 million across 1 funding round from investors including OurCrowd, Mediterranean Towers Ventures and The Kitchen Hub. MAOLAC offers products and services including Protein Blends. MAOLAC operates in a competitive market with competitors including The DuPont Nutrition and Health, Enzymotec, Advanced Enzyme Technologies, Zivo Bioscience and Kaffe Bueno, among others.
- Headquarter Jerusalem, Israel
- Founders Eli Lerner, Maya Ashkenazi, Ariel Orbach
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.2 M (USD)
in 1 rounds
-
Latest Funding Round
$3.2 M (USD), Seed
Jul 05, 2022
-
Investors
OurCrowd
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MAOLAC
MAOLAC offers a comprehensive portfolio of products and services, including Protein Blends.
Clinically-tested blends for adult health using AI technology.
People of MAOLAC
Unlock access to complete
Unlock access to complete
Funding Insights of MAOLAC
MAOLAC has successfully raised a total of $3.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $3.2 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $3.2M
-
First Round
First Round
(05 Jul 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Seed - MAOLAC | Valuation | OurCrowd |
Investors in MAOLAC
MAOLAC has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include OurCrowd, Mediterranean Towers Ventures and The Kitchen Hub.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investment in disruptive AgriFood-Tech startups is managed by experts.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by MAOLAC
Financial Statements - MAOLAC
Maolac Comparisons
Competitors of MAOLAC
MAOLAC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as The DuPont Nutrition and Health, Enzymotec, Advanced Enzyme Technologies, Zivo Bioscience and Kaffe Bueno, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufactures a range of health ingredients
|
|
| domain | founded_year | HQ Location |
Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses.
|
|
| domain | founded_year | HQ Location |
Enzymes are manufactured for nutrition, food, feed, and textile industries.
|
|
| domain | founded_year | HQ Location |
Bioactive compounds from algal strain
|
|
| domain | founded_year | HQ Location |
Coffee beans are supplied by Kaffe Bueno in multiple categories.
|
|
| domain | founded_year | HQ Location |
Natural cough remedies and wellness products are developed by Zarbees.
|
Frequently Asked Questions about MAOLAC
MAOLAC was founded in 2020 and raised its 1st funding round 2 years after it was founded.
MAOLAC is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Maya Ashkenazi is the current CEO of MAOLAC. They have also founded this company.
MAOLAC is a funded company, having raised a total of $3.2M across 1 funding round to date. The company's 1st funding round was a Seed of $3.2M, raised on Jul 05, 2022.
MAOLAC was founded in 2020 in Jerusalem, Israel, within the biotechnology and preventive health sector. Products enriched with antibodies and nutrients are developed from bovine colostrum through computational biology methods. Active immunological fractions are extracted to support immune function in humans and animals. Operations focus on creating nutritional solutions that address disease and inflammation risks, with applications in both human and veterinary health.
MAOLAC's top competitors include Advanced Enzyme Technologies, Zivo Bioscience and Enzymotec.
MAOLAC offers Protein Blends.
MAOLAC has 6 investors. Key investors include OurCrowd, Mediterranean Towers Ventures, The Kitchen Hub, The Food Tech Lab, and Mortgage Israel.